RefleXion

RefleXion

Private
Hayward, CaliforniaHealthcare & Life Scienceshttps://www.reflexion.com

Last Round

VC Round

11/15/2023

Total Funding Raised

$568.6M

Momentum Score

25 /100

Company Overview

RefleXion Medical is a healthcare technology company that develops biology-guided radiotherapy to create innovative cancer treatment solutions by utilizing positron emission tomography (PET) in conjunction with stereotactic radiotherapy for enhanced tumor localization and tracking during treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

biology-guided radiotherapyBgRTSCINTIX therapyradiotherapy platformPET-linacprecision radiotherapymetastatic cancer treatmentreal-time tumor trackingmotion management radiotherapyAI radiotherapylinacstereotactic body radiotherapySBRTstereotactic radiosurgerySRSintensity modulated radiotherapyIMRToncology techmedical capital equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RefleXion Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

RefleXion Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC Round11/15/2023
Debt7/6/2022
Series E3/10/2022
Series D Extension3/2/2021
Series D4/16/2020
Debt
5/1/2019

Key People

Founding team and executive leadership

Samuel Mazin

Founder And CTO

Founding Team

Todd Powell

President CEO

Executive Team

RefleXion Investors

Notable investors and investment history

InvestorRounds
Pictet GroupVC Round
Ascension VenturesSeries E
KCK Global LimitedSeries C
Sixty Degree CapitalSeries E
Ally Bridge GroupSeries D Extension
Ascension VenturesSeries E
Public Sector Pension Investment BoardSeries E, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    RefleXion X2 platform cleared for solid tumor radiotherapy.

  • Oct 1, 2025

    SCINTIX biology-guided radiotherapy technology recognized for lung tumors.

RefleXion Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RefleXion Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RefleXion's valuation, stock price, and market status.

Firmographic Details

HeadquartersHayward, California
Employee Range171
Year Founded2009
Last Funding11/15/2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.